ABSTRACT
Tuberculosis [TB] remains a global health problem. Treatment and prevention of TB has shifted from inpatient to outpatient settings. A report from the World Health Organization has emphasized educational strategy to ensure students graduate with the appropriate knowledge, skills, and attitudes essential to the effective management of TB. The objective of this study was to determine the level of knowledge, attitudes and practices among medical students. The survey was done from 2012 to 2013. Knowledge, attitudes and practices were assessed regarding tuberculosis with a questionnaire. Knowledge mean score of students was 16.13 +/- 2.06 and Attitude score was 36.08 +/- 3.76, Knowledge and attitude levels of students were moderate to high in the majority of them. Practice score of the study subjects was 22.77 +/- 4.95, 11.9% of students had poor practice level. 43% did not know that a sputum smear is the most important method used for diagnosis of TB. Two-thirds of them did not know the distance that should be kept from contagious patients. Half of them believed that the BCG vaccination has no role in the prevention of TB. This study concluded that more efforts should be made to improve the knowledge of students regarding TB transmission and the role of sputum smear in diagnosis. The importance of the BCG vaccination should be emphasized
ABSTRACT
Glucantime remains the first-line treatment for cutaneous leishmaniasis. In a prospective study, we evaluated its efficacy and side effects in patients treated in Yazd from 2010 to 2011. Patients with lesions compatible with cutaneous leishmaniasis were considered eligible for inclusion in this study if the disease was confirmed parasitologically. The exclusion criteria were as follows: the patient preferred a treatment modality other than Glucantime; there was no indication for treatment; the patient had underlying kidney, liver, or cardiac disease; or was pregnant and lactating. Patients with ?3 lesions and/or lesions <3 cm in diameter were treated with Glucantime intralesionally if the lesions were not located on the face, neck or joints; sporotrichoid; or superinfected with bacteria. All other patients were prescribed intramuscular Glucantime at 10-20 mg/kg/day for 20 days. The failure rate for patients treated with one course of Glucantime was 22.6% overall. There were no associations between age, sex, weight, the route of administration, the number and size of lesions, the adequacy of the dose of the drug injected intramuscularly, the number of intralesional injections [<6 or > =6] and the duration of therapy. The only factor associated with failure was reported previous exposure to antimony [p value 0.047]. Adverse effects occurred in 14.2% of patients [22/155]. Glucantime is an effective drug for the treatment of cutaneous leishmaniasis in central Iran. However, because cutaneous leishmaniasis heals spontaneously and to prevent the acquisition of resistance, the indications for treatment in each region should be defined carefully